Clinical Trial Update: Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating lenalidomide with low-dose dexamethasone in previously treated multiple myeloma patients with kidney dysfunction; study status termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: PrECOG, LLC. | Conditions: Multiple Myeloma, Plasma Cell Neoplasm | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-10-24